CDH1 and familial pancreatic carcinoma: Although aberrant methylation is a frequent epigenetic event for a number of genes in pancreatic cancer, in the present study, promoter methylation was present in only 4 of 9 investigated genes and only resulted in reduced mRNA expression one of them, CDH1.